Document Classification

Section Type: RESULTS

Text: There were no significant differences between the treatment groups in the incidence of proteinuric pre-eclampsia (6. 7 % aspirin-allocated compared with 6. 0 % placebo-allocated women), of preterm delivery (22. 3 % compared with 26. 1 %), of intrauterine growth retardation (8. 5 % compared with 10. 1 %), or of stillbirth and neonatal death (7. 3 % compared with 6. 0 %), nor were there significant differences in the incidence of proteinuric pre-eclampsia in any subgroup of women studied, including those who had systolic blood pressures of 120 mmHg or above at entry (8. 5 % compared with 7. 3 %) or those who were chronically hypertensive (10. 0 % compared with 7. 1 %).